Stimulant psychosis: systematic review

The British Journal of Psychiatry : the Journal of Mental Science
Catherine CurranAndrew McBride

Abstract

Psychosis associated with stimulant use is an increasing problem, but there is little research evidence about the nature of the problem and its management. To critically review the literature on stimulant psychosis and sensitisation. Systematic review of studies that have investigated stimulant use and psychosis in humans. The main outcome measures were increases in psychosis with stimulant use, and differences between stimulant users and non-users. Fifty-four studies met the inclusion criteria. Experimental studies show that a single dose of a stimulant drug can produce a brief increase in psychosis ratings (a "response") in 50-70% of participants with schizophrenia and pre-existing acute psychotic symptoms, unaffected by the presence of antipsychotic medication. Those with schizophrenia who do not have acute psychotic symptoms respond, but less frequently (30%). There has been little research into the longer-term effects of use. Compliance with antipsychotic medication by someone with schizophrenia will not prevent a relapse or worsening of psychotic symptoms if stimulants are used. Low-dose antipsychotic treatment may be beneficial in stimulant users, to prevent sensitisation.

References

Aug 1, 1977·The Journal of Nervous and Mental Disease·K GrafB S Comstock
Jun 1, 1976·The American Journal of Psychiatry·R M Post, R T Kopanda
Aug 1, 1992·Journal of Clinical Psychopharmacology·M D CarpenterL A Camus
Jan 1, 1991·Psychopharmacology·D RobinsonJ Lieberman
Dec 1, 1991·The American Journal of Psychiatry·S L Satel, W S Edell
Jan 1, 1990·Schizophrenia Bulletin·J A LiebermanA D Loebel
Jan 1, 1985·Psychopharmacology·B AngristJ Rotrosen
Jul 1, 1987·Archives of General Psychiatry·J A LiebermanJ Ramos-Lorenzi
Apr 1, 1988·International Clinical Psychopharmacology·D P van Kammen, J J Boronow
Jan 1, 1986·Psychopharmacology Bulletin·J A LiebermanJ Ramos-Lorenzi
Feb 1, 1986·Archives of General Psychiatry·F H Gawin, H D Kleber
Feb 1, 1973·Archives of General Psychiatry·D S JanowskyH J Sekerke
May 1, 1984·The American Journal of Psychiatry·J A LiebermanB Kinon
Jan 1, 1982·Psychopharmacology·B AngristJ Rotrosen
Aug 1, 1982·The American Journal of Psychiatry·D P van KammenJ N Rayner
Oct 1, 1995·The American Journal of Psychiatry·M R SerperA Werner
Jan 1, 1995·The Journal of Nervous and Mental Disease·L K PawlukM W Mahowald
Oct 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J A LiebermanJ M Kane
Jan 1, 1993·The Journal of Nervous and Mental Disease·J P SeibylD S Charney
Feb 1, 1994·The Journal of Nervous and Mental Disease·P LysakerR Milstein
Jan 1, 1996·Psychopharmacology·M SanfilipoJ Rotrosen
Jan 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A R KoreenM Chakos
Jan 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E BartlettB Angrist
Jan 14, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S A Castner, P S Goldman-Rakic
Nov 24, 1999·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·E Cherland, R Fitzpatrick
Jan 14, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R M KirraneL J Siever
Feb 23, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·A DalmauB Brismar
Jul 13, 2000·Drug and Alcohol Dependence·C K FarrenT R Kosten
Jan 4, 2003·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Helen DermatisLaurence Westreich
May 15, 1937·British Medical Journal·E Guttmann, W Sargant

❮ Previous
Next ❯

Citations

Feb 15, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Georges VauquelinPhilip Seeman
Sep 14, 2006·Current Psychiatry Reports·Walter LingWalter Ling
Feb 22, 2012·Current Psychiatry Reports·Sibel AlgonKarin E Borgmann-Winter
Jul 19, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Philip Seeman
Aug 14, 2008·Molecular Psychiatry·S M BermanE D London
May 13, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kathryn M GillAnthony A Grace
Jun 13, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robert A LasserJean-Pierre Lindenmayer
Sep 15, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Karen D ErscheBarbara J Sahakian
Mar 29, 2008·Annual Review of Clinical Psychology·Elaine WalkerKevin Tessner
Oct 7, 2009·Journal of Attention Disorders·Canan KaratekinChristopher Bingham
Apr 13, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Zahra Alam MehrjerdiAlireza Noroozi
Feb 10, 2011·The Australian and New Zealand Journal of Psychiatry·Grant SaraHarvey Whiteford
Aug 21, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Andrea Susana HerreraJosé Antonio Fuentealba
Feb 18, 2005·Proceedings of the National Academy of Sciences of the United States of America·Philip SeemanTeresa Tallerico
Mar 1, 2014·The British Journal of Psychiatry : the Journal of Mental Science·Grant E SaraWayne C Hall
Mar 3, 2010·Annual Review of Clinical Psychology·Emma Barkus, Robin M Murray
Dec 12, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Jan-Peter van WieringenMartin C Michel
Dec 23, 2014·Case Reports in Psychiatry·Ruohollah SeddighBehnam Shariati
Mar 23, 2011·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Jørg Mørland
Jan 18, 2013·Journal of Mental Health·Bahareh FasihpourSeyed Vahid Shariat
Sep 14, 2007·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Carlo MarchesiCarlo Maggini
Feb 25, 2014·Journal of Substance Abuse Treatment·Hanna UosukainenJ Simon Bell
Sep 29, 2009·The International Journal on Drug Policy·Jennifer A McLarenWayne Hall
Aug 28, 2015·Nordic Journal of Psychiatry·Kristiina KivimiesJari Tiihonen
Feb 26, 2008·Journal of Substance Abuse Treatment·Suzette Glasner-EdwardsUNKNOWN Methamphetamine Treatment Project Corporate Authors
Sep 22, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·R E FeatherstoneP J Fletcher
Jan 24, 2007·Clinical Psychology Review·Lynsey GreggGillian Haddock
Nov 3, 2015·Journal of Psychiatric Research·Lauren V MoranDost Ongur
Feb 17, 2009·Synapse·Madeleine V KingKevin C F Fone
Jun 21, 2006·Synapse·Philip SeemanTomiki Sumiyoshi
Sep 14, 2006·Addiction·Rebecca McKetinLeanne Hides
Jun 8, 2007·The European Journal of Neuroscience·Hideo MatsuzakiKohji Sato
Dec 17, 2010·CNS Neuroscience & Therapeutics·Takahide Shuto, Akinori Nishi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here